about us

Robert DiCrisci

Chairman, CEO

Robert DiCrisci is the Founder, Chairman, CEO of Tri-Source Pharma, the parent company of NextSource Biotechnology, Ivaoes Animal Health and Amatheon Pharmaceuticals.

Mr. DiCrisci has over 20 years of leadership experience in the Healthcare, Pharmaceutical and Technology markets. He began his career as a Lead Project Manager of Business Development for the Microsoft Business Solutions client base operating within the Healthcare/Pharmaceutical space. As a Business Management and Computer Science educated/Certified Systems Engineer, he held strategic business development/technology management roles in companies such as Cosabella Inc., Health Coalition Inc., University of Michigan Health, AAA Auto Club Group, HRH Construction and Sirco Associates.

Upon moving from his previous business consulting role, he became an Executive Director for Medical Staffing Network (MSN), the largest publicly traded medical staffing firm in the nation. During his tenure, Mr. DiCrisci took part in a capital raise of $185M in equity and $120M in a debt facility. Shortly thereafter he worked with the financial team to prepare the company for its Initial Public Offering (IPO). Additionally, Mr. DiCrisci’s responsibilities included managing and integrated over 30+ M&A deals, opening over three hundred DeNovo locations nationwide and managing all corporate operations, IT, business development and finance departments which were comprised of over seven hundred employees and over 20,000 per diem nurses. As a rapid growth company, we achieved revenues exceeding $500M in annual sales. After leaving Medical Staffing Network, Mr. DiCrisci Co-founded Amatheon Pharmaceuticals and has spent over 14 years building it into the leading distributor of human approved specialty pharmaceuticals for use in the animal health sector nationwide. Mr. DiCrisci served as the President, CEO of Amatheon and was responsible for managing and overseeing all aspects of the business with special attention on finance, Information technology, sales, marketing and business development. While running Amatheon, Mr. DiCrisci then founded NextSource Biotechnology, an FDA approved manufacturer of brand and generic human drugs and Ivaoes Animal Health, an FDA approved manufacturer of veterinary approved Brand and Generic drugs. These two companies work together to Identify, consolidate and develop a pipeline of new animal approved drugs (Cross-Over Medications). These drugs are predominately sold into the animal health industry and represent a market value of $3B annually.

View LinkedIN Profile: www.linkedin.com/in/RobDicrisci